Clinical and Virological Response to Convalescent Plasma in a Chronic Lymphocytic Leukemia Patient with COVID-19 Pneumonia

The burden of COVID-19 remains unchanged for immunocompromised patients who do not respond to vaccines. Unfortunately, Omicron sublineages are resistant to monoclonal antibodies authorized in Europe so far, and small chemical antivirals have contraindications and toxicities that have not been studie...

Descripción completa

Detalles Bibliográficos
Autores principales: Belcari, Giovanni, Conti, Alberto, Mazzoni, Alessandro, Lanza, Maria, Mazzetti, Paola, Focosi, Daniele
Formato: Online Artículo Texto
Lenguaje:English
Publicado: MDPI 2022
Materias:
Case Report
Acceso en línea:https://www.ncbi.nlm.nih.gov/pmc/articles/PMC9319583/
https://www.ncbi.nlm.nih.gov/pubmed/35888185
http://dx.doi.org/10.3390/life12071098

Internet

https://www.ncbi.nlm.nih.gov/pmc/articles/PMC9319583/
https://www.ncbi.nlm.nih.gov/pubmed/35888185
http://dx.doi.org/10.3390/life12071098

Ejemplares similares